Exploratory Evaluation of [11C]MPC6827
NCT04575727
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Neurodegenerative Diseases
Alzheimer Disease
Amyotrophic Lateral Sclerosis
Interventions
DRUG:
[11C]MPC6827
Sponsor
Columbia University